Antibodies to Infliximab and Risk of Infusion Reactions in Patients With Inflammatory Bowel Disease
Author:
Publisher
Oxford University Press (OUP)
Subject
Gastroenterology,Immunology and Allergy
Reference37 articles.
1. American Gastroenterological Association Consensus Development Conference on the Use of Biologics in the Treatment of Inflammatory Bowel Disease, June 21–23, 2006
2. A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease
3. Infliximab in Crohn's Disease: First Anniversary Clinical Experience
4. Clinical Experience With Infliximab Therapy in 100 Patients With Crohn's Disease
5. The impact of infliximab infusion reactions on long-term outcomes in patients with Crohn’s disease
Cited by 144 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. No Correlation between Anti-drug Antibodies and Therapeutic Response in Tunisian Patients with Chronic Inflammatory Diseases Treated by TNF Blockers;Current Rheumatology Reviews;2024-09
2. Risk factors for infliximab-induced infusion reactions based on a retrospective study of medical information;Int. Journal of Clinical Pharmacology and Therapeutics;2024-07-01
3. Forecasted infliximab concentrations during induction predict time to remission and sustained disease control of inflammatory bowel disease;Clinics and Research in Hepatology and Gastroenterology;2024-06
4. Monitorización terapéutica de los fármacos biológicos en la enfermedad inflamatoria intestinal. Documento de Posicionamiento del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU);Gastroenterología y Hepatología;2024-05
5. Aktualisierte S3-Leitlinie Colitis ulcerosa (Version 6.2);Zeitschrift für Gastroenterologie;2024-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3